NunzioCamer/Bayesian-Denoising-CGM

The project is a specialized research implementation for Continuous Glucose Monitoring (CGM) data. With only 4 stars and 1 fork over a period of nearly 3 years, it shows virtually no market traction or community adoption. While the focus on 'colored, non-stationary noise' is technically specific, the implementation is effectively a static reference for a paper rather than a living tool. Defensibility is low because the core logic is a standard Bayesian framework applied to a specific domain, which could be replicated by any data scientist in the med-tech space. Frontier labs (OpenAI, Google) are unlikely to target this niche directly, but the project faces extreme competition from incumbent medical device manufacturers (Dexcom, Medtronic, Abbott) who utilize proprietary, hardware-integrated filtering algorithms. The displacement horizon is short because modern deep learning approaches for timeseries (like Transformers or specialized RNNs) have largely superseded traditional Bayesian denoising for complex biological signals in active research.